Diclofenac Sodium
Product Images NDC 61919-468

4 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 61919-468). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image Description (Label)

Image Description (Label)
DICLOFENAC SODIUM E/R 100 mg extended-release tablet packaging label from Direct RX, containing 30 tablets. The label notes it is a generic product for Voltaren and includes dispensing and manufacturing information. Storage instructions and discard after date details are also visible.*
FDA Label Image

Image Description (Sideeffects)

Image Description (Sideeffects)
Text panel listing serious and other side effects of a medication. Serious side effects include heart attack, stroke, high blood pressure, kidney problems, bleeding ulcers, anemia, and life-threatening allergic reactions. Other side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*
FDA Label Image

Image Description (Structure)

Image Description (Structure)
Chemical structure diagram of Diclofenac Sodium showing the arrangement of its benzene rings, chlorine atoms, amine, and carboxylate groups.*
FDA Label Image

Image Description (Warning)

Image Description (Warning)
A text panel detailing cardiovascular and gastrointestinal risks associated with NSAIDs and Diclofenac Sodium Extended-release Tablets. It notes increased risk of serious cardiovascular thrombotic events, myocardial infarction, stroke, and gastrointestinal adverse events like inflammation, bleeding, ulceration, and perforation. Warnings specific to patients with cardiovascular disease and elderly patients are highlighted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.